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ABSTRACT  Protein factors derived from skeletal muscle separately promote neurite elongation 
and acetylcholine synthesis in cultured rat ventral spinal neurons. Morphologic factor activity 
(neurite-inducing activity) is specifically found in rat skeletal muscle and cord neuron extracts, 
decreases  with  the  postnatal  age of the  rats from  which  muscle  extract  is  prepared,  and 
increases in rat hindlimb muscle  after 5 d of denervation. Cholinergic factor actMty (acetyl- 
choline synthesis-stimulating activity) is found  in extracts  of rat cerebral cortex and cardiac 
muscle in addition to spinal cord and skeletal muscle, increases with animal age, and decreases 
following 5 d of denervation. Biochemically, the factors  responsible  for these activities differ 
in their lability to denaturing conditions, apparent molecular weights,  isoelectric points, and 
lectin-binding specificities.  Under reducing conditions,  morphologic  activity  is isolated  in a 
single  acidic  glycoprotein  with  an  Mr  of  35,000,  while  acetylcholine  synthesis-stimulating 
activity  is  found  in  multiple  species  of  different  molecular  weights.  Thus,  acetylcholine 
synthesis-promoting  activities  and  neurite  growth-promoting  activity  appear  to  reside  in 
different molecules. Significant  purification of several of these factors  has been achieved. 
Skeletal muscle, the target organ for motoneurons, influences 
the  survival,  growth,  and  differentiation  of its  innervating 
neurons.  In  avian  and  mammalian  embryos,  procedures 
which reduce or block muscle function in vivo subsequently 
prevent  the  death  of many  motoneurons  (53),  delay  the 
reduction  of polyneuronal connections (3,  42),  and induce 
motoneuron neurite sprouting (10).  Electrical stimulation of 
such denervated skeletal muscle blocks this terminal sprouting 
in neurons (7) and increases the rate of loss of polyneuronal 
innervation (47).  These developmental effects have been at- 
tributed to skeletal muscle-derived neurotrophic factors act- 
ing in a retrograde fashion on motoneurons (24,  54). 
The  main  evidence  for the  existence  of such  diffusible 
neurotrophic  factors comes from in  vitro experimentation. 
Media conditioned on cultured myotubes and skeletal muscle 
homogenates have been shown to augment motoneuron sur- 
vival (2,  57,  61),  general neuron phenotypic appearance in- 
cluding  neurite  elongation  (15,  27,  60),  and  motoneuron 
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neurotransmitter induction (20, 21, 60). However, since these 
muscle-derived activities have not been substantially purified, 
it is not clear whether a single factor possesses both morpho- 
logic and cholinergic properties, or whether multiple factors 
are involved. In vitro experiments with embryonic parasym- 
pathetic (45) ganglia suggest that several agents can separately 
influence different aspects of neuron development. Molecular 
sieving has been used to separate the ciliary neuron morpho- 
logic- and cholinergic-enhancing activities (45). 
In vivo experiments with spinal cord also suggest differen- 
tial regulation of motoneuron development. In rat and chick, 
the critical periods for motoneuron survival (13,  25, 35), loss 
of polyneuronal connections (6), and cholinergic differentia- 
tion (30,  52) occur at different developmental stages. Process 
density and hyperinnervation in surviving motoneurons are 
greatest at the stage of motoneuron death (24),  while subse- 
quent postnatal loss of polyneuronal innervation is not ac- 
companied by additional loss of motoneurons (35, 49).  Fur- 
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pharmacological  blockade,  motoneuron  neurite  sprouting 
from adjacent axons increases (5, 67), while there is a decrease 
in their capacity to synthesize and transport neurotransmitter 
(26, 29, 48). 
We have previously demonstrated that skeletal muscle ex- 
tract  increases  both  neurite  outgrowth  and  acetylcholine 
(ACh) m  synthesis in  cultures of dissociated embryonic rat 
ventral spinal cord (60). In  the present paper,  we provide 
evidence suggesting  that the  effects of muscle  extract  on 
neurite outgrowth and ACh synthesis in vitro are differentially 
regulated, and that the molecules possessing  morphologic- 
and cholinergic-cnhancing properties have distinctly different 
physical properties which can be readily separated by several 
biochemical techniques. Furthermore, we report the partial 
purification of a  morphologic-enhancing factor which  has 
no cholinergic-stimulating activity, and several  cholinergic- 
enhancing factors without apparent morphologic-enhancing 
activity (58, 59). 
MATERIALS  AND  METHODS 
Tissue culture media were purchased from Gibeo Laboratories (Grand Island, 
NY).  Horse  serum was obtained  from Kansas City Biologicals Inc. (Kansas 
City,  MO), and was heat  inactivated  at 50"C for 45  rain before addition  to 
media.  All  chemicals  used  were  of analytical  grade.  Radiochemieals  were 
purchased  from New England  Nuclear (Boston, MA), except for [3H]choline 
chloride, which was obtained  from Amersham Corp. (Arlington Heights, IL). 
All purification steps were performed on ice or in a cold room set to 4-7"C. 
Cell  Culture:  Neuronal cultures were prepared  from the dissociated, 
arachnoid-free  ventral  spinal cords of 13-14<I embryonic  rats (Zivic-Miller, 
Allison Park, PA). Spinal cords were first separated longitudinally  into dorsal 
and ventral  portions.  Ventral  cord portions were then pooled,  exposed to a 
0.08% trypsin solution at 37"C for 15 min, and dissociated by gentle trituration 
through a fire-polished pasteur pipette. The dissociated cells were plated onto 
polylysine-coated Falcon tissue culture dishes (Falcon Labware, Becton, Dick- 
inson & Co.,  Oxnard,  CA). For morphologic  assays, ceils were plated  at a 
density of 520 cells/ram 2 on 35-mm culture dishes. For assays of  ACh synthesis 
and accumulation,  cells were either  treated  as above, or plated  at a  fivefold 
higher  density  (2,500  cells/mm  2)  onto 24-well  multiwell  plates.  Cells were 
maintained  in Dulbecco's  modified  Eagle's medium supplemented  with  10% 
horse serum, 2 mM glutamine, 33 mM glucose, and 0.15 mM Garamycin.  One 
half day  after plating,  cytosine arabinoside  (5  x  10  -~ M) was added  to this 
medium for 12 to 24 h, to retard the proliferation of non-neuronal  cells. After 
cytosine arabinoside  removal, tissue extract fractions were added in constant 
volumes (usually 50 #l/ml culture medium) of a sterile saline solution. Half of 
the culture medium was exchanged every other day, and extract fractions were 
replaced with each feeding. 
Tissue Extract Preparation:  All tissue extracts were prepared  from 
Sprague-Dawley rats. Washed tissue was homogenized in 3 vol (wt/vol) of 10 
m M Dulbecco's phosphate-buffered saline (PBS) (137 mM NaCI, 2.7 mM KCI, 
8.1  mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) with  1 mM EDTA,  0.5 mM 
EGTA, and 2 mM phenylmethylsulfonyl  fluoride, and centrifuged at 32,000 g 
for 1 h. The resulting supernatant (SO was re-centrifuged for 2 h at 100,000 g. 
The final supernatant ($2: crude extract) was dialyzed against PBS for 12-24 b 
at 4"C, and filter sterilized through 0.22-pro Millex disposable filters (Millipore/ 
Continental  Water  Systems, Bedford, MA) before use. This supernatant was 
used  for all  subsequent purification  steps and experiments.  Muscle extract, 
unless  otherwise  indicated,  was  prepared  from  the  limb skeletal  muscle  of 
newborn rats. 
Biological Assays:  Where possible, the  same cultures were used for 
testing both cell process outgrowth and ACh synthesis. Alternatively, identical 
sister cultures were used for different biological assays. The results of multiple 
experiments  were usually pooled  and expressed as a percent  of the  relevant 
control  culture biological activity for each experiment.  By this method, differ- 
ences in control values were minimized, allowing better comparison of  changes 
in biological activities. 
i Abbreviations  used in  this paper:  ACh, acetylcholine;  a-BTX,  a- 
bungarotoxin; DTT, dithiothreitol; IEF, isoelectric focusing; MWCO, 
molecular weight cut-off;  NEM,  N-ethylmaleimide;  P/C  ratio,  the 
ratio of processes per cell. 
To determine  the yield of these biological activities from muscle extracts, a 
biological activity unit was defined. One unit is that amount of  sample required 
to produce a 50% stimulation over control levels, either in cell process density, 
or in ACh synthesis. Activity levels could be determined from activity/concen- 
tration curves for each sample, and quantitated  by the best linear or logarithmic 
curve fit of the resultant concentration  analysis data (r: > 0.9). 
To test extract samples  for denaturation  by pH, protease,  nuclease, heat, 
and  reducing  agents,  concentrations  corresponding  to  initial  half-maximal 
biological activity were used to plot the rate of  change in factor activity. Unless 
otherwise described in the text,only just-saturating concentration data has been 
presented. 
ACh Synthesis:  De novo ACh synthesis and accumulation  was mea- 
sured after 6 d in culture by a modification of Johnson and Pilar's assay (29). 
Cultures were depolarized for  l0 min in a Tyrode's  buffer with 25 mM KC1 
(to deplete existing stores of ACh), and then incubated  in normal Tyrode's 
solution  containing  l0 pM [3H]choline chloride  (2--4 Ci/mmol, Amersham 
Corp.) for 30 min. The cultures were washed with PBS three times to remove 
unused radioactive substrate, and extracted with  15:85 1 N formate/acetone, 
containing  J4C-labeled tetraethylammonium  bromide  as an internal  standard 
(New England Nuclear). These formic acid/acetone  extracts were transferred 
to glass test tubes and dried by vacuum centrifugation.  The contents  of each 
tube were then resuspeoded in 2 ml of HEPES-buffered Tyrode's solution, pH 
7.2, without potassium, and an aliquot was taken for measurement of choline 
uptake. Samples were centrifuged for 20 min at 2,500 g, and the supernatant 
(containing  the  choline  and  ACh)  was  collected  and  split  into  two equal 
fractions. One fraction from each well was treated with 0.02 U acetylcholines- 
terase (Boehringer-Mannheim  Biochemicals, Mannheim,  FRG) at 37"C for 10 
min.  Free choline  was phosphorylated  by adding  0.02 U  of choline  kinase 
(Sigma Chemical Co., St. Louis, MO),  l0 mM ATP,  l0 mM MgCI2, and  l0 
pM eserine sulphate in 10 mM Tris buffer (final oH in solution was 8.2). The 
ACh was separated from phosphorylcholine by extraction in tetraphenylboron/ 
acetonitrile (19), and carried into a toluene scintillint upper phase, which was 
removed for counting.  The amount of ACh synthesis and accumulation  was 
determined by first correcting for the loss of internal standard, and then taking 
the  difference  between  the  esterase-treated  and  untreated  fractions  as  the 
amount of [~H]ACh in each well. [3H]ACh synthesis and accumulation  was 
normalized to cell concentration  by analysis of  the DNA content in each culture 
well, and was expressed as the number of picomoles of [~H]ACh/~g DNA per 
hour. 
Morphometric  Assay:  Cultured  cells were  examined  for  process 
outgrowth by phase-contrast  microscopy. As an indicator  of average process 
density, the ratio  of processes per cell (p/c ratio) was measured  3-4 d after 
extract addition. This ratio was obtained by counting the number of processes 
with lengths greater than one cell diameter in random microscopic fields, and 
dividing by the total number of cells in each field. Cell counts were checked by 
plate DNA analysis, and cell viability at the time of counting was periodically 
tested by trypan blue exclusion. Twenty to sixty microscopic fields, representing 
between  1-3% of the total  dish  surface area,  were counted  for each  plate. 
Process lengths in these fields were also measured, using  a radicule. Periodically, 
process length and density measurements were photographically verified. 
Rat Denervation:  6-wk-old Sprague-Dawley rats were denervated un- 
der ether anesthesia by cutting and removing a 0.5-cm  section of the sciatic 
nerve at the level of the greater trochantor,  or by injecting 2 ug/hindlimb per 
day of a-bungarotoxin  (a-BTX)  (Miami  Serpentarium  Laboratories,  Miami, 
FL) every day. Completeness of denervation was tested each day by assessment 
of  resislance to forced hindlimb flexion and by loss of  reflex hindlimb extension. 
These results were verified at the time of muscle harvest by measurement  of 
denervation-dependent  increase  in flexor hallucus  longus  muscle  extrajunc- 
tional ACh receptors, using an adaptation of  the method of  Pestronk et aL (50). 
6 h before death,  iodinated  a-BTX (41) was injected into all rat hindlimbs. 
Flexor hallucus longus junctional  regions were identified by staining for acetyl- 
cholinesterase after death,  and then dissected free from most extrajunetional 
tissue by cutting the muscles into equal halves. Low affinity ~2sI  a-BTX binding 
was displaced by a short incubation with excess cold toxin, and specific receptor 
binding was then measured by gamma counting. 
Denaturation:  The sensitivities of muscle extract to heat and protease 
were tested using the Sz fraction. Thermal lability of the extract was determined 
by incubatng 0.5-ml aliquots at 60"C for intervals of from 5 to 60 min in a 
constant temperature shaking water bath. The samples were then cooled on ice 
and centrifuged to remove any precipitate that formed during the incubation. 
Procedures for assay of muscle extract trypsin sensitivity are described in Fig. 
5B. After each incubation  interval, extract aliquots were immediately  placed 
on ice and treated  with  1 mg/ml soybean trypsin  inhibitor  for 30  min.  All 
samples were dialyzed in  12,000-14,000  molecular  weight cut-off (MWCO) 
dialysis Spectropor 4 membranes  (Spectrum Medical, Los Angeles, CA) for 12- 
16 h against three changes of PBS, pH 7.4, and filter sterilized (Millex 0.22-um 
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Nuclease sensitivity was tested using ribonuclease A and deoxyribonuclease 
1,  purchased  from  Boehringer-Mannheim  Biochemicals  (Mannheim,  Ger- 
many).  Enzyme  incubations  were performed  after  treatment  of the  muscle 
extract with 2 mM phenylmethylsulfnnyl fluoride. 
The pH stability of the trophic activities was examined by dialyzing aliquots 
of muscle extract  at 4"C in different  phosphate  or citrate-phosphate  buffers 
ranging from pH 3 to pH 11. The aliquots were then titrated  back to pH 7.4, 
centrifuged  for  10  rain  at 2500 g,  filter sterilized, and tested  for biological 
activity. 
Precipitation by Ammonium Sulfate:  Ammonium sulfate frac- 
tionation  was performed at 0*C by the dropwise addition  of 3.9 M (NFLhSO4 
(Schwarz/Mann  Div,, Spring Valley, NY) to crude muscle extract. Ammonium 
sulfate concentration  was increased in steps to complete saturation.  After each 
step  addition,  extract  samples  were  allowed  to  equilibrate  for  1.5  h,  and 
precipitated proteins  were then pelleted by a 30-min centrifugation  at  15,000 
g. Precipitates were resuspended in '/5 their original volume, and dialyzed for 
! 2-16 h through 6-8,000  MWCO Spectropor  I membranes  against either PBS, 
or PIPES buffer (Calbiochem-Behring Corp., La Julia, CA) containing 25 mM 
NaCI. Dialyzed samples were stored at -80"C for further use, or filter sterilized 
for assay. 
Preparative Isoelectric Focusing (IEF):  IEF was performed at 6"C 
on an LKB Multiphor  2117 apparatus.  A Sephadex IEF gel slurry (Pharmacia 
Fine  Chemicals,  Uppsala,  Sweden), containing  muscle  46-60%  ammonium 
sulfate fraction mixed with pH 4-9 ampholines (Serva Fine Biochemicals Inc., 
Garden City Park, NY), was poured into an electrophoresis tray and focused 
at 8 W constant  power for 16 h. At the end of the run, protein  banding  was 
determined by overlaying a strip of Whatman 1 paper (Whatman Inc., Clifton, 
N  J) on the edge of the gel surface. This paper print was removed, fixed in 10% 
trichloroacetic  acid, and developed  with Coomassie  Blue. The gel was then 
separated into 30 fractions, and a small aliquot of each fraction was collected 
for pH determination.  Protein contained  in the remainder of each fraction was 
eluted by the method of Winter et at. (69), using alternating 0.5-ml washes of 
PBS and 0.5  M NaCI in  PBS. Eluled  proteins  were dialyzed through  1,000 
MWCO dialysis membranes and concentrated threefold by lyophilization prior 
to assay of biological activity. 
Gel Filtration Chromatography:  Gel  filtration  steps  were  per- 
formed  in  LKB  and  Pharmacia  columns.  Sizing column  flow  rates  were 
maintained  with  an  LKB  2132 Microperpex  peristaltic  pump. All  column 
fractions were collected on Gilson Microfractionator (Gilson Medical Electron- 
ics, Inc., Middleton,  WI) fraction collectors. UV absorbance  was assayed for 
each fraction at 280 nm on a Gilford 250 spectrophotometer  (Gilford Instru- 
ment Laboratories, Inc., Oberlin, OH). 
Muscle extract samples were dialyzed in  l0 mM phosphate/50 mM NaCl 
buffer, pH 6.8, and  then  fractionated  on  either  a  2.5  x  85-cm column of 
Sephacryl S-200 equilibrated  at a  flow rate  of 40  ml/h, or a  1.0  x  90-cm 
column containing  LKB ACA-202 standardized at a rate of 12 ml/h. Grouped 
fractions from each column were dialyzed through Spectropor 6 1,000 MWCO 
membranes against one<luarter  normal PBS solution, and concentrated  four- 
fold by lyophilization before addition to cultures. 
Determination of GIycoprotein Nature, and Lectin-Affinity 
Chromatography:  Sodium  periodate,  cyanogen  bromide-activated 
Sepharose  4B,  and  the  lectins  Triticum  vulgaris, Arachis  hypogaea.  Lotus 
tetrogonobolus, Concanavalin A, and Lens culinaris were obtained from Sigma 
Chemical Co. a-Mannosidase,/~-glucosidase, neuraminidase, and Limulin were 
purchased from Boehringer-Mannheim  Biochemicals. Glycosidases and lectins 
were first conjugated  to cyanogen bromide-activated  Sepharose 4B (51, 65), 
and then poured into mini econo-columns  from Bio-Rad Laboratories, Rich- 
mand, CA. The specific binding  activities of these lectin-coupled beads were 
assayed using radiolabeled sugars. After removal of  radiolabeled tracers, muscle 
fractions were then added to the lectin columns. Choice of running and elution 
buffers depended  upon the specific lectin-sugar  pair (51, 65). Columns were 
washed in 20 vol of lectin-specific buffer, and bound molecules then eluted in 
2-5 ml of buffer containing  100 mM (50 mM for sialic acid) specific eluting 
sugar. Samples were dialyzed against '%  normal PBS solution  through  1,000 
MWCO Spectropor 6 membranes, and concentrated fourfold by lyophillization 
prior to testing biological activity. 
Other Procedures:  Lactate dehydrogenase  activity (45) and acetyl- 
cholinesterase activity (18) were both assayed on homogenates of spinal cord 
cultures either  12 h after initial cell plating, or after 5 d in vitro. Cultures were 
assayed either in the absence or 4-d presence of 200 ug skeletal muscle extract/ 
ml culture medium. Protein content was assayed by the technique of Lowry et 
al.  (38) or by  fluorimetric  assay (64). Culture  DNA assays were performed 
according to the method  of Hinegardner (28). 
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RESULTS 
Under our culture conditions, 95% of added cells attached to 
dish substrata within 1 h of plating. When plated at a density 
of 500 cells/mm  z, 37  +  7% of the cells remained bound to 
the culture dish after 6 d in vitro (4 d after removal of cytosine 
arabinoside). At the higher plating density of 2,500 cells/mm  2, 
apparent cell survival was 50 __. 8%. 85 __.  10% of these cells 
were labeled by the neuron-selective marker protein tetanus 
toxin. 
Approximately one-fifth of the plated cells began to extend 
processes within  12  h  of attachment. Although this process 
extension was influenced by plating density and by culture 
glial content,  the  addition  of skeletal muscle extract  inde- 
pendently augmented both the rate and extent of cell process 
outgrowth (Fig.  1). When measured 3 d after the addition of 
saturating concentrations of muscle extract, process density 
increased from 0.36  ___ 0.01  processes per cell  in  untreated 
cultures, to  1.51 _  0.05  processes per cell in extract-treated 
cultures. The percentage of  tetanus toxin-labeled cells extend- 
ing  neurites  also  increased  relative to  total tetanus  toxin- 
labeled cells, from 20 +  5% without treatment, to 60 _  5% 
after muscle extract addition.  Comparable increases in  cell 
process length were observed, from an average of 50 ___ 1 #m 
in controls, to 163 _+ 5 #m after 3 d in extract-supplemented 
cultures. These effects were not due to the binding of a muscle 
extract component to the polylysine substratum, since a  16-h 
extract-substratum incubation  before cell addition  had  no 
effect on neural process outgrowth, measured 3 d after plating. 
Further, muscle extract addition neither altered total or teta- 
nus toxin-labeled cell survival, as determined by cell counting 
and culture DNA content, nor enhanced general cell metab- 
olism. Culture acetylcholinesterase activity increased only 15 
_  5% relative to control values after 4  d  in  200 #g extract 
protein/ml culture medium, while extract similarly produced 
an insignificant 10 _  6% increase in total lactate dehydrogen- 
ase activity compared to control cultures (even though lactate 
dehydrogenase activity increased in both extract and control 
cultures by threefold during the 4-d test period). 
Changes in cell morphology occurred more rapidly than 
did increases in cholinergic activity. Maximal process density 
was achieved after 3-5 d in culture, while ACh synthesis and 
accumulation continued to increase in vitro for at least 3 wk. 
When measured 4 d after the initial addition, the rate of ACh 
synthesis and accumulation in these cells typically increased 
threefold,  from 2.52  +  0.24  pmol  [3H]ACh  synthesized/~g 
DNA per hour in control cultures, to 7.98 ___ 0.34 pmol [3H]- 
ACh/#g DNA per hour in  muscle extract-treated neurons. 
Factor activities, however, varied somewhat between individ- 
ual extract preparations. The concentration of muscle extract 
required to give a half-maximal increase in ACh synthesis in 
spinal  neuron  cultures (50  /zg protein/ml culture  medium) 
was only one-fourth of that necessary for the same change in 
either process density (200 #g protein/ml culture medium) or 
process length. These findings suggest  that factors regulating 
process density and ACh synthesis in ventral spinal cord may 
be  different.  Three  biological  criteria  are  described  below 
providing further evidence for this hypothesis. 
Tissue Specificity 
Fig. 2 provides evidence that extracts of different newborn 
rat tissues differentially augment neurite outgrowth and cho- FIGURE  |  Effect of addition (three consecutive days) of muscle extract on neurite extension in cultured ventral spinal cord cells. 
Control cultures (a) were maintained in normal growth medium, while experimental cultures were further treated with 25 (b), 
100 (c), or 400 (d) #g muscle extract protein/ml of culture medium. Bar, 100/~m. x  250. 
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FIGURE  2  Effect  of  different  neonatal  rat  tissue  extracts on  (a) 
neurite  density and  (b)  [3H]ACh  synthesis  and  accumulation  in 
cultured ventral cord neurons. ExiTacts  of spleen (SP), liver (LI), lung 
(LU), skin  (SK), kidney  (K/), cerebral cortex (CC), cardiac muscle 
(CM),  skeletal muscle (SM), or spinal cord  (SC) were individually 
added in equal 200/zg extract protein/ml culture medium aliquots 
linergic activity. 3 d after the addition of 200 ug protein/ml 
extract aliquots to ventral cord cultures, only skeletal  muscle 
and  spinal  cord  homogenates  significantly  stimulated  cell 
process outgrowth. In sister cultures, cholinergic activity was 
not only increased by skeletal muscle and spinal cord extracts, 
but also by homogenates of other tissues with dense cholin- 
ergic innervation, such as cardiac muscle and cerebral cortex. 
Even at higher concentrations, these latter two extracts  had 
little effect on process outgrowth, suggesting that an increase 
in cholinergic activity is apparent with two tissue extracts that 
do  not  promote  morphologic  differentiation.  Neurite  out- 
growth in heart and brain extracts was not actively prevented 
by  the  production  of a  specific  inhibitory  factor,  because 
mixing just-saturating activity levels of skeletal muscle extract 
with activity-saturating levels of cardiac muscle extract prior 
to cell addition did not block process outgrowth. 
Age Dependence 
The cholinergic and morphologic activities of muscle ex- 
to triplicate cultures. In each experiment, cultures were assayed 3 
d later for neurite outgrowth. Additionally, triplicate sister cultures 
were tested after 4  d  for the amount of [3H]ACh synthesizedl/~g 
DNA per hour, relative to control (CO) values. These results are the 
means  of  four experiments _+  SDs. The value for  mean  control 
morphologic activity was 0.47 processes per cell with an  interex- 
periment SD of 0.31, and an intraexperiment SD of 0.14. The ACh 
synthesis  mean value was 2.45  pmol [3H]ACh/#g DNA  per hour 
with an SD between experiments of 0.89, and an SD of 0.07 within 
an experiment. 
SMITH ET AL.  Separation of Rat Motoneurotrophic  Factors  161 1 tract also display different age dependencies. The levels of 
morphologically active factor obtained from muscle extracts 
of different aged rats decreased with the  increasing age of 
those rats (Fig. 3). When expressed per milligram of muscle 
protein (Fig. 3A), there was an 80% loss in this activity during 
the first 3 wk after birth. Morphologic activity levels obtained 
from the combination of newborn and adult muscle extracts 
suggested that this loss was the result of  a decrease in activating 
factor concentration rather than an increased amount of an 
inhibitory substance. In contrast, cholineric-stimulating activ- 
ity in older animal muscle was at least slightly greater than 
that found in newborn tissues. When expressed as total activ- 
ity per  limb,  a  400%  increase  in  cholinergic activity was 
observed with maturation (Fig. 3 B). 
Response to Denervation 
To determine whether the age-dependent changes in mor- 
phologic and cholinergic factor activities could be reversed by 
axotomy, we examined the results of physical (sciatic  nerve 
ligation) or chemical (repeated hindlimb injection with  a- 
BTX) denervation of adult rat hindlimb muscle on in vitro 
tests of these two indices of neuron maturation. Both of these 
methods produced a loss of distal hindlimb function within I 
d of treatment, and a  35-fold increase in muscle extrajunc- 
tional ACh receptor levels (measured by '2sI-a-BTX binding) 
at the time of muscle homogenization. 
After denervation, the low morphologic-stimulating  activity 
of adult muscle extract increased almost to newborn activity 
levels (Fig. 4). With combined physical and chemical dener- 
vation, there was no further increase in morphologic activity. 
In  contrast,  the  high  adult  cholinergic-stimulating activity 
decreased after either ligation of  a-BTX-induced denervation. 
None of these responses were a result of the brief exposure of 
all gastrocnemius muscles to '25I-a-BTX.  There was no dif- 
ference in  either parameter  of development when  muscle 
extract prepared from control animals 6 h after '25I-a-BTX- 
injection was compared to muscle extract prepared from non- 
injected, age-matched controls. 
Differential  Effects of Denaturation 
The morphologic-  and cholinergic-enhancing activities of 
muscle extract could be separated by their biochemical as well 
as biologic properties. For example, they differed with respect 
to their rates of heat inactivation. Although both factor activ- 
ities were destroyed by heating to 60"C for l  h, the morpho- 
logic factor lost activity more rapidly than did the cholinergic 
factor (Fig.  5A).  At 60"C, this rate of morphologic activity 
loss  was  nonlinear, and appeared to follow an exponential 
curve with half-maximal activity decay at 8.8  min. At just- 
saturating activity concentrations, the rate of loss in cholin- 
ergic activity with heating was linear, with half of its activity 
being lost in 29 rain. 
Morphologic- and cholinergic-stimulating  activities also dif- 
fered in their rates of inactivation by trypsin. In the presence 
of 0.1  mg/ml trypsin at 37"C, loss  of morphologic activity 
followed a  linear  time  course,  with  a  %/2  of inactivation 
observed at 48 min (Fig. 5 B). Loss of cholinergic activity was 
nonlinear with time, however, and could be modeled by two 
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FIGURE  3  Comparison of rat limb muscle development to muscle extract-induced changes in neurite extension and cholinergic 
development in vitro. Extracts of rat hindlimb muscle, obtained at ages ranging from birth to 6 wk, were added to ventral spinal 
cord cultures. Although multiple extract protein concentrations were tested, this figure depicts the results (for each rat age) of 
addition of single subsaturating I00 pg muscle extract protein/ml culture medium concentration, on process density (O), measured 
after 3 d, or on [~H]ACh synthesis (O), assayed 4 d after initial extract addition. For each experiment, data from triplicate cultures 
are expressed as a percent of newborn extract activity (100%), relative to control culture values (0%). The results are normalized 
per mg muscle extract protein in a, or per limb (b), and are the mean of four experiments (12 cultures per point) _  SEM. Actual 
mean values for process outgrowth are 0.41  +_ 0.19/0.09 for control and 1.63 +_ 0.30/0.17 for newborn extract-treated cultures, 
where interexperiment SD is expressed above intraexperiment SD. Comparable mean values for cholinergic activity were 2.59 + 
0.66/0.09  pmol  [3H]ACh//zg  DNA  per hour, and 5.62  -  0.74/0.16 pmol  [3H]ACh/pg  DNA  per hour for  control and newborn 
extract-treated cultures, respectively. 
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FIGURE 4  Denervation-induced changes in process density and cholinergic activity. Muscle extracts were prepared 5 d  after 
distal hindlimb denervation, either by cutting the sciatic nerve (11), by daily injections of 2 ~g a-BTX per limb per day (A),  by a 
combination of these two methods (O), or after sham operation and daily saline injections (&).  These extracts were added to 
dissociated ventral spinal cord neurons. Concentration-dependent effects of the extracts were assayed  in triplicate cultures 3 d 
after initial addition for differences in (a) the P/C ratio or in (b) [~H]ACh synthesis,  measured in triplicate sister cultures after 4 d. 
Results are expressed as a percent of untreated culture values, and are the mean of three experiments (9 cultures per point) + 
SEM. Control mean values for morphologic and cholinergic activities were 0.63 -  0.27/0.10 processes  per cell, and 2.21  _+ 0.74/ 
0.14 pmol [3H]ACh//~g  DNA per hour, respectively (mean control value +  interexperiment SD/intraexperiment SD). 
lines that provided an activity loss tl/21  at 16 min and a  tl/22 
at 23  min.  This effect was blocked by pretreatment of the 
enzyme with  1  mg/ml  soybean trypsin  inhibitor.  Neither 
extract incubation at 37"C, nor addition of soybean trypsin 
inhibitor to extract, had any effect on the activities induced 
by muscle extract. 
The cholinergic and morphologic activities exhibited differ- 
ent sensitivities to pH (Fig.  5 C).  The morphologic activity 
was  stable  at  acid  pH,  but  was  destroyed above  pH  7.5. 
Conversely, cholinergic-stimulating activity was  stable  be- 
tween pH 6 and 9, with only partial activity being lost below 
pH 6.  Total cholinergic activity was destroyed, however, at 
pH greater than 9. 
Both activities were stable to a 6-h incubation with either 
DNAase I  or RNAase A.  Further, neither activity was lost 
when incubated with disulfide reducing agents like 1-5 mM 
dithiothreitol (DTT)  or  2-mercaptoethanol.  In  fact,  when 
tested at subsaturating activity concentrations, a  12-h incu- 
bation with 2 mM DTT increased total cholinergic activity in 
muscle extract by 2.2-fold. This increased activity was  pre- 
served after subsequent incubation with  2-5  mM N-ethyl- 
maleimide (NEM).  Because DTT and NEM  were dialyzed 
from the extract before addition to cultures, these agents did 
not directly effect the survival or differentiation of the cells. 
Precipitation by Salts 
Both morphologic- and cholinergic-stimulating activities of 
muscle extract could be reversibly precipitated by the step- 
gradient addition of ammonium sulphate. Most morphologic 
factor activity and cholinergic factor activity was precipitated 
and recovered in the 47-62%  saturated ammonium sulfate 
fraction of muscle extract. When morphologic- and cholin- 
ergic-stimulating activities were also tested for susceptibility 
to denaturation at high salt concentrations, both were stable 
to 2 M NaC1, but were labile to treatment with 6 M guanidine 
hydrochloride. 
Separation by Size 
As a direct test for the presence of multiple neurotrophic 
species,  the active 46-62%  ammonium sulfate sample was 
fractionated by Sephacryl S-200 gel filtration chromatography 
(Fig.  6).  In the presence of the reducing agents  DTT and 
NEM, a single morphologically active species was found with 
an M, of 33,000-37,000 (Fig. 6 C). In contrast, two peaks of 
cholinergic activity were found, with Mr's of 55,000-65,000 
and  14,000-17,000 (Fig.  6D).  If DTT and NEM were not 
added to the  extract before S-200  sizing  chromatography, 
morphologic activity eluted as several activity peaks with M,'s 
averaging greater than  200,000,  125,000,  100,000,  67,000, 
and  33,000  (Fig.  6A).  Omission  of DTT  and  NEM  also 
increased the  number of cholinergic activity peaks.  These 
species  eluted with  M,'s  of greater than  200,000,  75,000- 
85,000,  55,000-65,000,  40,000-45,000,  and  14,000-17,000 
(Fig. 6B). 
Under both nonreducing and reducing conditions, morpho- 
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FIGURE 5  The effects  of heat,  trypsin,  and extremes  of pH  on the  loss of muscle  extract morphologic factor activity and 
cholinergic factor activity. Muscle extracts were (a) heated to 60°C for 5-60 min, (b) incubated for 90 min at 37°C (E) with either 
soybean trypsin inhibitor (E+S) or trypsin inactivated by 1 mg/ml soybean trypsin  inhibitor (S+T+E), treated with active 0.1 rag/ 
ml trypsin for 5-90 min, or (c) dialyzed for 6 h against different buffered solutions of pH 3-11  prior to addition to cultures. Prior 
to use, trypsin  and soybean trypsin  inhibitor (Sigma Chemical Co.), were both assayed for proteolytic activity with the protease 
substrates toluene-sulphonyI-L-arginine methyl ester  and  benzoyI-L-arginine  ethyl  ester.  In  each  experiment, samples were 
assayed in triplicate ventral spinal cord cultures for either neurite outgrowth (0), or ACh synthesis ((3). Reported results of heat 
and trypsin  denaturation of muscle extract are the mean of three experiments (9 cultures  per point) --- SEM, whereas assays of 
extract pH stability are the mean of two experiments (6 cultures per point) + SEM. Control values for morphologic activity were 
0.34 ___ 0.02  processes/cell for a, 0.58  +  0.23/0.09 processes for b, and 0.35 +  0.06/0.04  for c. Control values for cholinergic 
activity were 2.42 _  0.57/0.20 pmol [3H]ACh//~g DNA per hour for a, 2.13 + 0.88/0.14  pmol [3HjACh/#g  DNA per hour for b, 
and 2.55 _-4:. 1.22/0.17 pmol [3H]ACh/#g  DNA per hour for c.  Results refer to the mean control values +  interexperiment SD or 
range/intraexperiment SD. This method for normalizing biological activity provides  consistent  quantitative comparisons,  both 
between preparations of muscle extract, and between experiments. 
logic activity was quantitatively recovered from the gel filtra- 
tion column (Table I).  In contrast, most of the cholinergic 
stimulating  activity  added  to  the  S-200  column  was  not 
recovered (Table II). Prior to reduction, total recovered activ- 
ity accounted for 30% of that originally added to the column. 
Addition  of DTT  and  NEM,  even  though  increasing  the 
recovery of  activity in the 55,000-65,000 and 14,000-17,000- 
mol-wt peaks, decreased total recovered cholinergic-stimulat- 
ing activity to only 20% of that added to the column. 
Since much ACh synthesis-inducing activity was lost by 
passage  through  the  S-200  column,  a  similar  ammonium 
sulfate fraction was added to an LKB ACA-202 sizing column. 
On this column (which we empirically found to resolve pro- 
tein molecular weight standards in the range of  25,000-2,000), 
morphologic-stimulating activity eluted in a single peak at the 
column void volume, while four cholinergic factor activity 
peaks were identified. The first peak of activity eluted at the 
void volume (presumably corresponding to the 55,000-mol- 
wt factor), while other cholinergic peaks eluted with M/s of 
16,000-18,000,  5,000-7,000,  and  2,000.  Total  cholinergic 
activity recovery was -77% (Table III). The lowest molecular 
weight cholinergically active peak has since been resolved by 
Bio-Rad P-6 and P-2 gel chromatography to an approximate 
molecular weight of 1,200-1,500 (40). 
Separation by Preparative IEF 
Morphologic and cholinergic activities also had different 
apparent isoelectric points (Fig.  7). After electrofocusing of 
the 46-62% extract ammonium sulfate fraction, morphologic 
activity was usually found to focus as a single band at pH 4.8, 
while the cholinergic activity focused as multiple bands at pH 
9.2,  7.7,  5.2, and 4.1.  On occasion, a very small amount of 
morphologic activity was  also found at  a  pH  range corre- 
sponding to a pI of 7.5-8. 
The Mr's of the four cholinergically active IEF fractions 
were determined by gel filtration on S-200 or ACA-202  gels. 
Samples were pooled by pI activity peak and concentrated by 
lyophilization prior to addition to a sizing column. Cholin- 
ergic activity initially recovered from the basic fraction (pI = 
9.2), eluted from an ACA-202  column at an Mr of 14,000- 
18,000 (Fig. 8A). The fraction corresponding to a pI of 7.7 
contained an activity peak with an Mr of 55,000-65,000, and 
when chromatographed on ACA-202, also produced a second 
activity peak with an M, of 5,000-8,000 (Fig. 8B). The pH 
5.2  and 4.1  fractions contained only low molecular weight 
(<5,000)  cholinergically active  species.  After  S-200  sizing 
chromatography, the morphologically active isoelectric frac- 
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FIGURE  6  Separation of morphologic and cholinergic factor activities by Sephacryl S-200 molecular sieving chromatography, 
with or without prior reduction and alkylation. A 2.0-ml aliquot of a 46-62% ammonium sulfate-precipitated fraction of muscle 
extract was added to a Sephacryl S-200 sizing column, and each group of four consecutively eluted 2.5-ml fractions was pooled 
and  added  to  triplicate  cultures  for  bioassay of  neuron  process  outgrowth  (a),  and  ACh  synthesis  (b).  After  reduction  and 
alkylation, an identical extract sample was fractionated on the same column, and assayed in triplicate cultures for extract fraction- 
induced changes in neuron process density (c) or ACh synthetic activity (d).  Comparison of the absorbance at 280 nm of each 
fraction  (--)  with  its  corresponding  pooled fraction  biological activity is depicted  for  both column  elutions.  Each  activity bar 
represents the mean of two different assays for these fractions (six cultures total) ±  SD. Control values for morphologic activity 
were 0.78 ___ 0.21/0.05 processes per cell for unreduced fraction experiments, and 0.88 _  0.28•0.06  for reduced fraction tests, 
where values refer to the mean +  interexperiment range•  mean intraexperiment SD. Control values for ACh synthesis were 1.64 
_  0.64/0.13 pmol [3H]ACh/#g DNA per hour for assays with unreduced fractions, and 2.87 ±  1.19/0.31  pmol [3H]ACh/pg DNA 
per hour. Molecular weight standards shown are ferritin (F), subunits of aldolase (AI-4),  bovine serum albumin (AL), ovalbumin 
(O), chymotrypsinogen (CH), and Ribonuclease A  (R). 
TABLE  I.  Morphologic Activity:  1,140 Units Added to Column 
Before reduction  After reduction and alkylation 
Size  Specific activity  Total activity  Specific activity  Total activity 
mol wt  Ulmg protein  U  U/rag protein  U 
250,000  203 +  16  105 ±  6  0  0 
115,000-125,000  32 ±  5  70 ±  5  0  0 
63,000-67,000  1,415 -+ 150  455 ±  25  0  0 
33,000-36,000  1,360 -+ 125  313 ±  13  4,457 ±  305  1,425 __+ 72 
Recovery and fractionation of factor activities by sizing chromatography. Results are primarily derived from the column fractionation experiment depicted in 
Fig. 3. Morphologic-specific activity from Sephacryl S-200 columns  were assessed in peak activity fractions  by regression analysis of activity/concentration 
curves. Total activities were determined from all fractions contributing to a peak. The data are accompanied  by the range for each value, as delineated from 
the regression curves. Average total recovery (92% before reduction and 124% after reduction and alkylation) was obtained from five different S-200 column 
fractionation experiments. 
tion yielded  a  single  activity  peak  with  an  Mr  of 34,000- 
38,000 (Fig. 8 C). 
Additivity of Cholinergic Activities 
When tested together on cultured cells, the cholinergically 
active  ammonium  sulfate  fractions  produced  additive  in- 
creases in cholinergic activity. To test whether the four cho- 
linergic gel  filtration  fractions  might  also  provide  additive 
stimulations of ACh synthesis, active species were first par- 
tially purified by ammonium sulfate fractionation, ACA-202 
gel chromatography, and preparative  IEF. As previously ob- 
served (Figs. 6D and 8B), the 55,000-mol-wt factor provided 
a smaller maximal stimulation at saturating activity than did 
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FIGURE  7  Biological activity profile from  pre- 
parative  IEF  of a  46-62%  ammonium  sulfate 
fraction of muscle extract. Morphologic factor 
activity (---)  and cholinergic factor activity (--) 
obtained from  triplicate  culture  assays  of  IEF 
fractions, depicted as a function  of the pH of 
each  fraction.  Results  are the  mean  of three 
experiments  (9  cultures  per  point)  ±  SEM. 
Mean control values for morphologic and cho- 
linergic  activity  were  0.65  ±  0.18/0.03  proc- 
esses/cell and 2.70 ±  1.06/0.07 pmol [3H]ACh/ 
t~g DNA per hour,  where interexperiment SD 
is expressed above intraexperiment SD. 
TABLE II.  Cholinergic Activity:  1,880 Units Added to Column 
Before reduction  After reduction and alkylation 
Size  Specific activity  Total activity  Specific activity  Total activity 
real wt  U/mg protein  U  U/mg protein  U 
250,000  651  ±  63  214 ±  20  0  0 
75,000-85,000  86 +  42  117 ±  57  0  0 
55,000-65,000  96 +  10  67 ±  7  100 +  11  62 +  7 
14,000-17,000  4,250 ±  618  136 ±  26  7,143 ±  1,587  343 ±  76 
Recovery and fractionation of factor activities by sizing chromatography. Results are primarily derived from the column fractionation experiment depicted in 
Fig. 3. Cholinergic-specific activity from Sephacryl S-200  columns were assessed  in peak activity fractions by regression  analysis  of activity]concentration curves. 
Total activities were determined  from all fractions contributing  to a peak. The data are accompanied by the range for each value, as delineated from the 
regression curves. Average total  recovery (32% before reduction and 21% after reduction  and alkylation) was obtained from five different  S-200 column 
fractionation experiments. 
TABLE III.  Cholingic Activity: 4,400 Units Added to Column 
After reduction and alkylation 
Size  Specific activity  Total activity 
mol wt  U]mg protein  U 
25,000  145 +  21  200 -  21 
14,000-17,000  1,000 +  46  1,580 ±  88 
5,000-7,000  400 ±  15  194 ±  31 
2,000  30,000  1,394 ±  13 
Recovery and  fractionation  of factor  activities  by sizing chromatography. 
Results are  primarily  derived  from  the  column  fractionation  experiment 
depicted in Fig. 3. Cholinergic-specific activity from LKB ACA-202 columns 
were assessed in peak activity  fractions by regression analysis of activity] 
concentration  curves. Total  activities  were  determined  from  all  fractions 
contributing  to a peak. The data are accompanied by the range for  each 
value, as delineated from the regression  curves. Average total recovery (77%) 
was obtained  from  three  different  ACA-202 column  fractionation  experi- 
ments. 
any of the other three smaller species (Fig.  9A).  Moreover, 
even though these three lower molecular weight fractions had 
comparable saturating activity levels, their maximal activities 
were  significantly  less  than  that  of the  crude  high  speed 
supernatant. 
When the 55,000-mol-wt  factor was added to any of the 
lower  molecular weight  species,  the  combined  cholinergic 
activity was equal  to that  found in  the crude  homogenate 
(Fig. 9B). However, when the lower molecular weight factors 
were mixed with one another and added to cultures, no such 
additivity of cholinergic factor stimulation was observed. 
Determination of Glycoprotein Nature 
Both the morphologic- and cholinergic-stimulating activi- 
ties  of skeletal muscle extract appeared to be produced by 
glycoproteins. Each activity was completely destroyed by a 
20-rain, 37"C incubation with 5 mM sodium periodate. This 
effect  was  not  the  result  of direct  damage  to  cells,  since 
periodate was removed by dialysis prior to addition to cul- 
tures. However, because periodate may have denatured mus- 
cle extract activities by some other action than the cis-diol 
cleavage of sugar groups, morphologic and cholinergic factor 
binding to lectin columns was also assessed (Table IV). Muscle 
extract fractions, each partially purified by ammonium sulfate 
fractionation,  sizing chromatography, and  preparative IEF, 
were added to lectin columns. Columns were then washed 
with 10-20 ml of a PBS carrier solution containing calcium, 
magnesium, and/or manganese ions, as needed, to stabilize 
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FIGuR~ 8  Sizing chromatography of biologically active IEF fractions. ACA-202 molecular sieving elution profile of the cholinergic 
factor activities associated with pls of (a) 9.0-9.5, and {b) 7.0-8.4. (c) Sephacryl S-200 chromatography fractionation of morphologic 
factor activity with pl of 4.5-5.1. Optical density at 280 nm is depicted, by elution fraction number, with the relevant biological 
activity obtained in each experiment by bioassay of quadruplicate cultures. Activity is depicted by bars, representing the increase 
above control values for a mean of two experiments (8 cultures per group) + SD. Control values for process outgrowth and ACh 
synthesis were 0.67 +_ 0.20/0.05 processes/cell,  and 2.69 _+ 0.41/0.14  pmol [3H]ACh//~g DNA per hour, where numbers refer to 
mean control activity levels _  range of values between experiments/mean SD of values within individual experiments. Sample 
volumes, fraction processing, and molecular weight standards shown are as depicted in Fig. 6. 
lectin-sugar binding. Glycoproteins were eluted with buffer 
containing an excess of the relevant specific lectin-binding 
sugars. 
The 34,000-37,000-mol-wt morphologically active factor 
bound  selectively to  Lens  culinaris,  concanavalin  A,  and 
Lotus tetrogonobolus lectins, and was eluted by a-methyl- 
mannoside (Table IV). Although these lectins all have speci- 
ficity for ~x-mannosyl (4,  34) residues, there was no loss  of 
morphologic factor activity when  muscle  extract fractions 
were incubated for 1 h with sepharose-linked/%glucosidase or 
a-mannosidase. 
The  cholinergically active  14,000-17,000-  and  55,000- 
60,000-mol-wt factors did not bind to concanavalin A or Lens 
lectin columns, but did bind to a sialic  acid-specific lectin, 
eluting with N-acetylneuraminic acid (Table IV). In addition, 
incubation of dialyzed muscle extract at 37"C with 0.1  U of 
sepharose-linked neuraminidase greatly reduced its ability to 
stimulate ACh synthesis (tt/2 =  7.5 rain), but had no effect on 
morphologic  factor activity.  The  lowest  molecular weight 
cholinergically active species did not bind to columns specific 
for either of these  sugar types, and  was  not  destroyed by 
neuraminidase. 
Factor Purification 
We have partially purified several of the biologically active 
muscle extract-derived species.  Beginning with ~100 ml of 
crude rat muscle homogenate, ammonium sulfate fractiona- 
tion, sizing gel chromatography, preparative IEF, and lecfin 
column chromatography were sequentially performed to in- 
crease the purity of some of the biologically active factors. By 
these methods, the morphologically active protein has been 
estimated to be purified ~75,000-fold with more than a 35% 
yield (Table V). 
The analysis of purification for the  14,000-17,000-  and 
55,000-60,000-mol-wt  cholinergic  factors,  however,  has 
posed problems. This difficulty was due to both the presence 
of multiple cholinergically active species  that contribute to 
the total biological activity, and to the continual problem of 
loss  of the low molecular weight factors from less purified 
fractions.  At  present,  the  55,000-60,000-mol-wt  factor is 
more than 100-fold more active, per mg protein, than is the 
crude muscle homogenate. There was a 3% recovery of chol- 
inergically active  material  in  this  molecular weight  range 
relative to total activity (Table V). The 14,000-17,000-mol- 
wt  factor has,  by the  same  scheme,  been purified almost 
3,700-fold with a final yield of 18%. 
DISCUSSION 
Our in vitro data indicate that skeletal muscle--derived trophic 
activities separately enhance spinal  cord neurite outgrowth 
and ACh synthesis. The biological evidence  for this conclusion 
is fourfold: (a) although both morphologic- and cholinergic- 
enhancing activities are present in extracts of skeletal muscle 
and spinal cord, cholinergic-stimulating activity is also selec- 
tively found in two tissues without morphologic activity (e.g., 
cardiac  muscle and  cerebral cortex); (b)  morphologic and 
cholinergic factor activities from muscle differ with respect to 
time  course  of action  and  concentration  dependence;  (c) 
morphologic-enhancing activity  declines  significantly as  a 
function of age, with skeletal muscle extracts from 3-wk-old 
rats possessing only 20% of  the activity of newborn rat skeletal 
muscle, whereas cholinergic-enhancing activity in muscle in- 
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FIGURE  9 
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Additivity of cholinergic factor activities. (a)  Maximal 
levels of factor-induced ACh synthesis (depicted here by solid bars) 
were  determined  by  preparation of activity/concentration curves 
for  each  of  the  size-separable  cholinergically  active  factors.  (b) 
Comparison of the maximal level of cholinergic-stimulating activity 
from crude muscle extract with levels obtained by adding together, 
at saturating concentrations, the partially purified cholinergic factor 
activities (indicated in the legend). Each bar represents the bioassay 
of triplicate cultures  for each  of two experiments +  SD.  Control 
values for cholinergic activity was 2.56 ±  0.39/0.24 pmol [3H]ACh/ 
#g  DNA  per  hour,  with  the  range of  interexperiment values ex- 
pressed above the mean SD for individual experiments. Phosphate- 
buffered  saline  carrier  (PBS), high  speed  supernatant  of  muscle 
extract (CR), and 55,000- (55),  17,000- (17), 6,000- (6),  and  1,500- 
(1.5)  mol-wt cholinergically active factors. 
creases over the same time period; (d) 5 d after denervation, 
extracts from adult rat skeletal muscle demonstrate a fourfold 
increase in  morphologic activity (per milligram  of muscle 
tissue), and a twofold decrease in cholinergic-enhancing  activ- 
ity. 
These changes in morphologic activity with age and dener- 
vation parallel the in vivo loss of rodent polyneuronal inner- 
vation (6) and enhancement of neurite sprouting (5, 7), sug- 
gesting decreases and increases respectively in the availability 
of muscle-derived trophic agent (46,  55). Likewise,  the age- 
dependent increase in cholinergic-enhancing activity tested in 
vitro independently follows in vivo motoneuron neurotrans- 
mitter differentiation (8,  30),  while the loss  in cholinergic- 
stimulating activity after denervation correlates with reversi- 
ble decreases in neurotransmitter synthesis and transport in 
vivo  after  nerve  crush  or  ligation  (26,  48).  The  separate 
developmental time courses for these effects in  vitro bear 
similarities to in vivo data on the time course of  retinal neuron 
embryonic development (56) and post-axotomy neuron dif- 
ferentiation (26, 47, 67). Such results suggest the existence of 
two or more trophic activities,  although they alone do not 
rule out the separate actions of  a single trophic substance (63). 
The morphologic- and cholinergic-enhancing activities in 
crude muscle extract have different sensitivities  to heat, pro- 
tease digestion, and changes of pH (Table VI).  While these 
biochemical tests also do not define the existence of separate 
factors, direct evidence for factor separation comes from the 
chromatographic properties of these activities.  Under reduc- 
ing conditions, gel filtration provided a single peak of mor- 
phologic activity, and  several peaks  of cholinergic activity 
(each devoid of endogenous ACh synthetic activity). Similar 
results have been obtained when muscle extract was fraction- 
ated by IEF and ion exchange chromatography, providing 
several  fractions with cholinergic activity and a single major 
fraction  with  morphologic  activity.  Finally,  lectin-affinity 
chromatography separated the  morphologic protein, which 
appears to be an a-mannosyl residue-containing glycopeptide 
(4,  34),  from several cholinergic species.  These cholinergic 
species could themselves be subfractionated into those which 
contained  essential  sialic  acid  residues  and  those  without 
apparent sugar moieties. Using the protocol defined in this 
paper,  we have achieved a  75,000-fold purification of the 
35,000-mol-wt morphologic factor, which migrates as a single 
TABLE IV.  Lectin Binding Specificity  of Factor Activities 
A. 
Lectin  Eluting sugar  Activity in wash  Activity in eluate 
% total added +- SD  % total added +_ 5D 
Triticum vulgaris  n-Acetylglucosamine  103 ±  12  8 ±  16 
Arachis hypogaea  Galactose  104 ±  20  3 ±  18 
Lotus tetragonobolus  L-Fucose  99 4- 33  53 ±  32 
Concanavalin A  a-Methylmannopyranoside  24 ±  15  90 ±  22 
Lens culinaris  a-Methylmannopyranoside  27 ±  21  105 ±  20 
Limulin  N-Acetylneuraminic acid  86 4- 15  15 _+ 20 
Lens culinaris  a-Methylmannopyranoside  --  (a)  -- 
Concanavalin A  a-Methylmannopyranoside  105 ±  17  (b)  4 _+ 20 
Limulin  N-Acetylneuraminic acid  90 +  15*  (a)  12 ±  17 
86 +  30*  (b)  5 _+ 20 
4 -  6  (a)  98 ±  15 
34±  12  (b)  54±  16 
Binding and  recovery of morphologic factor activity (A) and cholinergic factor  activity (B) from various  immobilized lectins.  Values presented are the 
percentage of total activity applied to each lectin column and recovered in the buffer wash, or in the displacement sugar eluate. 
* Data for (a) 55,000- and (b) 17,000-mol-wt  factors. 
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Treatment  Specific activity  Purification  Total activity  Yield 
U/mg protein  U  % 
Morphologic (35,000 mol wt) factor 
activity 
Tissue homogenate  <1  --  --  -- 
100,000 g supernatant*  10  1  5,100  100 
46-60% (N H4)2SO4 fraction  122  12  4,670  92 
S-200 sizing chromatography  4,456  446  3,910  77 
Preparative IEF  384,600  38,500  2,295  45 
Lectin chromatography  747,000  75,000  1,940  38 
Cholinergic factor activity 
Tissue homogenate  <2  --  --  -- 
100,000 g supernatant*  17  1  5,500  100 
46-60% (NH4)=SO4 fraction  190  11  5,450  99 
S-200 sizing chromatography  105'  (a)  6 (a)  200 (a)  4 (a) 
1,000'  (b)  59 (b)  1,600 (b)  29 (b) 
935  (a)  55 (a)  170 (a)  3 (a) 
22,730  (b)  1,337 (b)  1,150 (b)  21  (b) 
2,055  (a)  123 (a)  170 (a)  3 (a) 
66,250  (b)  3,680 (b)  970 (b)  18 (b) 
Preparative IEF 
Lectin chromatography 
* Also referred to as crude muscle extract. 
:[: Data for (a) 55,000- and (b) 17,000-mol-wt factors. 
TABLE Vl.  Summary of Physical Properties for the Morphologic and 
Cholinergic Factor Activities of Muscle Extract 
Treatment  Morphologic activity  Cholinergic activity 
Heat  Labile t,/21 60 ° =  9  Labile t,,~ =  29 min 
min 
Labile t,/22 60 ° =  31 
min 
Trypsin  Labile t,/2 37 ° =  48  Labile t,hl =  16 min 
rain  Labile t,/22  =  23 rain 
pH  Stable at acidic pH  Maximal activity at 
Labile at basic pH  pH 5-8.5 
DTT  Stable  Stable 
/3-Mercaptoetha-  Stable  Stable 
nol 
NEM 
Periodate 
Neuraminidase 
Stable 
Labile 20 min at 
37°C 
Stable 
a-Mannosidase  Stable 
ff'-Glucosidase  Stable 
Lectin binding  Con A, Lens, Lotus 
Ammonium sul-  35-60% 
fate 
DEAE-cellulose  0.1-0.3 M  NaCI 
CM-cellulose 
pl  4.8 
Sizing (post-re-  33,000-35,000-mol- 
duction)  wt 
Stable 
Labile 20 min at 
37°C 
Partial loss t,/2 =  7.5 
min 
Stable 
Stable 
Limulin 
47-62% 
0.70-0.95 M  NaCI 
0.04-0.08 M  NaCI 
0.25-0.40 M  NaCI 
0.55-0.62 M  NaCI 
0.9-1.0 M  NaCI 
9.2, 7.7, 5.2, 4.1 
50,000-60,000-mol- 
wt 
14,000-17,000-mol- 
wt 
5,000-7,000-mol-wt 
1,200-1,500-mol-wt 
band on one-dimensional SDS gel electrophoresis, and lesser 
degrees of purification for the various cholinergic factors. 
Our results are consistent with in vivo experimental data, 
and  extend previous work  using  co-cultured muscle  (20), 
conditioned medium from cultured myotubes (15,  21, 27), 
and extracts of muscle tissue (58, 60) to stimulate spinal cord 
development. Further, our data complement recent work by 
other groups. For example, several attempts have been made 
to purify motoneurotrophic factors using assays that measure 
only total neuron survival and cell process outgrowth. Since 
motoneurons comprise a small percentage of ventral spinal 
cord cells, though, it is possible that their survival and devel- 
opment are regulated differently than other cord neurons (46, 
61).  Thus, even though the age and denervation-dependent 
changes in our morphologic activity paralleled specific effects 
on  in  vivo  motoneuron  neurite  sprouting  and  retraction, 
>60%  of the neurons in the cultures increased neurite out- 
growth in response to factor addition. It may not be surprising, 
then, that other reported molecular weights for soluble factors 
effecting  general spinal cord (16, 27, 62), cortical neuron (33), 
and parasympathetic motoneuron (17) survival and process 
sprouting are roughly equivalent to our reported values for 
nonreduced morphologic factor aggregates.  Under reducing 
conditions, our total morphologic activity was quantitatively 
recovered as a 35,000-mol-wt acidic glycoprotein factor. Sim- 
ilarly, the bovine brain factor that directs neurite outgrowth 
in dissociated bovine cortical neurons is also a single acidic 
37,000-mol-wt glycoprotein (33). 
These  morphologically active,  soluble  proteins  augment 
neurite growth rate (16) in a different manner than do sub- 
stratum-binding proteoglycans (37), which are mechanically 
essential for cell substratum attachment and subsequent neu- 
rite  outgrowth  (1 l).  Although  a  few  reports  (9,  36)  have 
suggested that a substrate-binding proteoglycan complex con- 
taining laminin is the only neurite-promoting factor present 
in muscle-derived fractions, our morphologic factor neither 
bound to dish substratum nor altered serum components. It 
thus behaves more like a previously reported soluble substance 
which augments neurite outgrowth in cultures already con- 
taining the substratum-bound factor (12). 
Tests of cholinergic activity are more selective of motoneu- 
ron function than are general in vitro morphologic assays. 
Thus, the identification of cholinergic-enhancing factors by 
several groups (20, 2 I, 32, 45, 57, 60, 68) may provide more 
specific insights  into motoneuron development than can ob- 
servation of general growth or survival agents.  Yet, our sepa- 
ration of spinal  cord neuron  morphologic and  cholinergic 
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rotrophic hormone which specifically  enhances both repro- 
neuron process outgrowth and neurotransmitter synthesis.  In 
fact, the  detection of such  a  factor has been suggested  by 
muscle extract IEF.  From several gels, we isolated a  small 
amount of mophologic activity at a pI corresponding to that 
of the 55,000-mol-wt cholinergic-enhancing factor. This heat- 
labile,  neutral 55,000-mol-wt glycoprotein further appears to 
have selective effects on in vitro motoneuron development. 
When added to ventral cord neuron cultures at saturating 1- 
5 ug/ml concentrations, it promoted both neurite outgrowth 
and cholinergic development in choline acetyltransferase-an- 
tibody-labeled neurons,  without altering motoneuron sur- 
vival,  the  survival and  morphologic development of other 
cord neurons or non-neuronal cells, or culture protein content 
(61). Equivalently specific in its actions is the 50,000-mol-wt 
protein from iris muscle-containing eye extracts that induces 
cholinergic activity in ciliary ganglion motoneurons without 
affecting general neuron growth or non-neuronal cell division 
(45). Further, monoclonal antibodies directed against a simi- 
lar  56,000-mol-wt  neurotrophic  species  (or  a  co-purifying 
antigen)  have  selectively  prevented  denervation-induced 
sprouting in motoneurons (23). 
Several other reports have identified acid-extractable, heat- 
stable 50,000-60,000-mol-wt proteins derived from heterol- 
ogous  sera  or  whole  rat  embryos,  which  generally act  to 
promote "neuronotypic" cell survival (31) and mesodermal 
cell mitogenesis (39). However, the effects of our high molec- 
ular weight cholinergic factor were normally observed in the 
presence of serum-containing media, and were additive to the 
actions of horse and calf serum on choline acetyltransferase 
antibody-labeled cell growth and cholinergic activity. There- 
fore, this protein is probably not such a serum-derived factor. 
Our 55,000-mol-wt species was additive to each of  the three 
lower molecular weight species in reconstituting the maximal 
cholinergic-enhancing activity of the unfractionated extract. 
Further, the  14,000-17,000-mol-wt glycoprotein (which has 
a pI of-9.2), had a very different effect on general cell growth 
than did the high molecular weight factor. At factor concen- 
trations equal to its cholinergic-stimulating levels, the 14,000- 
17,000-mol-wt species increased culture protein synthesis, and 
induced a 2-3-fold increase in cell division when added to rat 
L6  myoblasts,  3T3  fibroblasts,  and  primary  rat  astrocytes 
(Smith,  R.  G.,  unpublished  results).  This  species  may be 
analogous to a recently purified 20,400-mol-wt protein from 
eye extract (1), which augments the survival and growth of 
ciliary ganglionneurons, and complements the function of a 
50,000-mol-wt cholinergic factor (45). It is also similar in its 
actions to basic (pI =  9.0) 40,000-45,000-mol-wt cholinergi- 
caUy active proteins isolated from skeletal and cardiac mus- 
cle-conditioned media, that increase choline acetyltransferase 
activity in cultured sympathetic neurons (68), and both cho- 
linergic activity and general cell growth in spinal cord neurons 
(32). During size fractionation of the skeletal muscle-derived 
factor, active  13,000-  and 7,000-mol-wt species  were some- 
times isolated, associated with a  decrease in activity of the 
40,000-mol-wt parent compound. We have similarly identi- 
fied a  minor 40,000-45,000-mol-wt cholinergic-stimulating 
factor component in  nonreduced,  size-fractionated muscle 
extract (Fig. 6 b), which is lost on reduction, commensurate 
with increasing 14,000-17,000- and 5,000-7,000-mol-wt fac- 
tor activity. 
Although our low molecular weight species may be proteo- 
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lytic fragments of larger species, several other 25,000-38,000- 
mol-wt cationic trophic glycoproteins have been shown to 
readily dissociate into 13,000-17,000-mol-wt subunits in the 
presence of reducing agents. The members of this genetically 
related family of substances (44),  including platelet-derived 
growth factor, p28  as, and fibroblast-derived growth factor, all 
contain functionally important disulfide linkages, have pls in 
the range of 9-10, and (though not tested for neurotrophic 
activity) have  similar  mitogenic actions  on  fibroblast and 
glioblast cell populations (14, 66). 
The smallest (1,200-mol-wt)factor accounts for most of the 
observed ACh  synthesis-stimulating activity. Since muscle 
extracts were usually dialyzed before reduction and sieving 
chromatography, this peptide was also probably derived from 
larger molecular weight species, either by reduction of disul- 
fide bonds or by proteolysis of precursor proteins (22). Yet, 
several lines of  evidence suggest that the low molecular weight 
species is not a product of the 55,000-mol-wt protein. When 
tested together, the  activities of the  low  molecular weight 
factor and high molecular weight factor were additive, thereby 
implying different mechanisms of action. Additionally, both 
the 17,000 and the 55,000-mol-wt factors selectively attached 
to an n-acetylneuraminic acid-specific lectin column and lost 
most activity after treatment with neuraminidase, while the 
low (1,200) molecular weight factor neither bound to sialic 
acid-specific columns nor was inactivated by neuraminidase. 
Because  another  recent  report  describes  the  neurotrophic 
effects of a low molecular neurotrophic peptide (43), peptides 
may  also  serve  as  trophic  agents,  helping  to  support  the 
survival and development of neurons. 
The later stages  of motoneuron development, including 
terminal  axon elongation to  muscle cells,  competition for 
survival,  and induction of neurotransmitter synthesis, all ap- 
pear to require interactions with the skeletal muscle target 
tissue. In a previous paper, we showed that soluble extracts of 
skeletal muscle could reproduce in vitro the effects of muscle 
cells  on  spinal  cord  neuron  morphologic and  cholinergic 
differentiation (60).  In the present report, we have demon- 
strated that two trophic activities present in muscle extract 
can be differentiated by their respective functional dosages, 
tissue distribution, age of animals from which the extract was 
prepared, and state of innervation. Additionally, the proteins 
responsible for these separate activities are biochemically dis- 
tinct. Some of the cholinergically trophic species indentified 
in this paper may act through different mechanisms to in- 
crease ACh synthetic levels,  either by inducing neurotrans- 
mitter synthesis, or by stimulating cholinergic neuron survival 
(61). Further, the physical properties of  some of  these proteins 
bear similarities to other reported trophic agents. 
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